Literature DB >> 29442176

The cortical blood-brain barrier in multiple sclerosis: a gateway to progression?

Jack S Bell1, Jonathan I Spencer1, Richard L Yates1,2, Gabriele C DeLuca3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29442176     DOI： 10.1007/s00415-017-8727-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  Magnetic resonance imaging of blood-brain barrier permeability in ischemic stroke using diffusion-weighted arterial spin labeling in rats.

Authors:  Yash V Tiwari; Jianfei Lu; Qiang Shen; Bianca Cerqueira; Timothy Q Duong
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients.

Authors:  Stig P Cramer; Henrik B W Larsson
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-30       Impact factor: 6.200

Review 3.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

4.  Inflammatory cortical demyelination in early multiple sclerosis.

Authors:  Claudia F Lucchinetti; Bogdan F G Popescu; Reem F Bunyan; Natalia M Moll; Shanu F Roemer; Hans Lassmann; Wolfgang Brück; Joseph E Parisi; Bernd W Scheithauer; Caterina Giannini; Stephen D Weigand; Jay Mandrekar; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

5.  Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging.

Authors:  Guido Stoll; Christoph Kleinschnitz; Sven G Meuth; Stefan Braeuninger; Chi Wang Ip; Carsten Wessig; Ingo Nölte; Martin Bendszus
Journal:  J Cereb Blood Flow Metab       Date:  2008-10-29       Impact factor: 6.200

6.  Cortical lesion load associates with progression of disability in multiple sclerosis.

Authors:  Massimiliano Calabrese; Valentina Poretto; Alice Favaretto; Sara Alessio; Valentina Bernardi; Chiara Romualdi; Francesca Rinaldi; Paola Perini; Paolo Gallo
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

7.  Cortical remyelination: a new target for repair therapies in multiple sclerosis.

Authors:  Ansi Chang; Susan M Staugaitis; Ranjan Dutta; Courtney E Batt; Kathryn E Easley; Anthony M Chomyk; V Wee Yong; Robert J Fox; Grahame J Kidd; Bruce D Trapp
Journal:  Ann Neurol       Date:  2012-10-17       Impact factor: 10.422

Review 8.  Imaging blood-brain barrier dysfunction in animal disease models.

Authors:  Andreas Wunder; Karl Schoknecht; Danica B Stanimirovic; Ofer Prager; Yoash Chassidim
Journal:  Epilepsia       Date:  2012-11       Impact factor: 5.864

9.  Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.

Authors:  Richard L Yates; Margaret M Esiri; Jacqueline Palace; Benjamin Jacobs; Rafael Perera; Gabriele C DeLuca
Journal:  Ann Neurol       Date:  2017-08-19       Impact factor: 10.422

10.  MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.

Authors:  Josefina Maranzano; David A Rudko; Kunio Nakamura; Stuart Cook; Diego Cadavid; Leo Wolansky; Douglas L Arnold; Sridar Narayanan
Journal:  Neurology       Date:  2017-07-19       Impact factor: 9.910
  10 in total
  2 in total

1.  Significant higher-level C-C motif chemokine ligand 2/3 and chemotactic power in cerebral white matter than grey matter in rat and human.

Authors:  Jingdong Zhang; Xinrui Gong; Huangui Xiong
Journal:  Eur J Neurosci       Date:  2021-03-16       Impact factor: 3.698

2.  Expression and Clinical Correlation Analysis Between Repulsive Guidance Molecule a and Neuromyelitis Optica Spectrum Disorders.

Authors:  Jinhua Tang; Xiaopeng Zeng; Jun Yang; Lei Zhang; Hang Li; Rui Chen; Shi Tang; Yetao Luo; Xinyue Qin; Jinzhou Feng
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.